GlassScriptPhysician profile
Gregory J Mowen
NPI 1568475572
$4,041.17
in general payments reported to CMS, 2019-2025
24 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $567 · 2021: $398 · 2022: $699 · 2023: $528 · 2024: $979 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,022.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $389.53 | 2019-2025 | Esprit |
| Nevro Corp. | $308.69 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $265.78 | 2024-2025 | Nuzyra |
| Stryker Corporation | $254.25 | 2019-2021 | |
| Averitas Pharma INC. | $249.98 | 2023-2025 | Qutenza |
| Medtronic, INC. | $243.00 | 2024 | Intellis Adaptivestim |
| Bard Peripheral Vascular, INC. | $231.17 | 2020 | |
| Kerecis Limited | $230.11 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $224.57 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $212.34 | 2019-2020 | |
| Treace Medical Concepts, INC. | $166.44 | 2023-2024 | |
| Paragon 28, INC. | $156.69 | 2021-2022 | |
| Globus Medical, INC. | $147.74 | 2025 | Senza |
| Horizon Therapeutics Plc | $142.21 | 2021-2023 | Krystexxa |
| Wright Medical Technology, INC. | $117.94 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $116.80 | 2024 | Krystexxa |
| Misonix INC | $113.96 | 2021 | |
| Organogenesis INC. | $113.83 | 2022-2024 | Cygnus Dual |
| Anika Therapeutics, INC. | $105.84 | 2022 | |
| Depuy Synthes Sales INC. | $84.82 | 2022 | |
| Smith+Nephew, INC. | $70.03 | 2019-2025 | Grafix Pl |
| Next Science LLC | $46.67 | 2022 | |
| Orthofix Medical, INC. | $32.90 | 2024 | Physio-Stim |
| Melinta Therapeutics, LLC | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.